<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Current Pediatric Reviews</journal-id><journal-title-group><journal-title xml:lang="en">Current Pediatric Reviews</journal-title><trans-title-group xml:lang="ru"><trans-title>Current Pediatric Reviews</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1573-3963</issn><issn publication-format="electronic">1875-6336</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">645682</article-id><article-id pub-id-type="doi">10.2174/1573396319666221205123402</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Medicine</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Hereditary Rickets: A Quick Guide for the Pediatrician</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>AlSubaihin</surname><given-names>Abdulmajeed</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Harrington</surname><given-names>Jennifer</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff id="aff1"><institution>Department of Pediatrics, College of Medicine, King Saud University</institution></aff><aff id="aff2"><institution>Division of Endocrinology, Women's and Children's Health Network</institution></aff><pub-date date-type="pub" iso-8601-date="2024-04-01" publication-format="electronic"><day>01</day><month>04</month><year>2024</year></pub-date><volume>20</volume><issue>4</issue><issue-title xml:lang="ru"/><fpage>380</fpage><lpage>394</lpage><history><date date-type="received" iso-8601-date="2025-01-11"><day>11</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/1573-3963/article/view/645682">https://journals.eco-vector.com/1573-3963/article/view/645682</self-uri><abstract xml:lang="en"><p id="idm46466589553584">With the increased discovery of genes implicated in vitamin D metabolism and the regu-lation of calcium and phosphate homeostasis, a growing number of genetic forms of rickets are now recognized. These are categorized into calciopenic and phosphopenic rickets. Calciopenic forms of hereditary rickets are caused by genetic mutations that alter the enzymatic activity in the vitamin D activation pathway or impair the vitamin D receptor action. Hereditary forms of phosphopenic rick-ets, on the other hand, are caused by genetic mutations that lead to increased expression of FGF23 hormone or that impair the absorptive capacity of phosphate at the proximal renal tubule. Due to the clinical overlap between acquired and genetic forms of rickets, identifying children with hereditary rickets can be challenging. A clear understanding of the molecular basis of hereditary forms of rick-ets and their associated biochemical patterns allow the health care provider to assign the correct di-agnosis, avoid non-effective interventions and shorten the duration of the diagnostic journey in these children. In this mini-review, known forms of hereditary rickets listed on the Online Mendeli-an Inheritance in Man database are discussed. Further, a clinical approach to identify and diagnose children with hereditary forms of rickets is suggested.</p></abstract><kwd-group xml:lang="en"><kwd>Rickets</kwd><kwd>hypophosphatemia</kwd><kwd>phosphaturia</kwd><kwd>hypercalciuria</kwd><kwd>hypocalcemia</kwd><kwd>vitamin D</kwd><kwd>FGF23.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Cone TE Jr. A rachitic infant painted by Burgkmair 136 years before Dr. Whistler described rickets. Clin Pediatr 1980; 19(3): 194. doi: 10.1177/000992288001900305 PMID: 6987020</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Clarke E. Whistler and Glisson on rickets. Bull Hist Med 1962; 36: 45-61. PMID: 13879755</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Dunn PM. Francis Glisson (1597-1677) and the "discovery" of rickets. Arch Dis Child Fetal Neonatal Ed 1998; 78(2): F154-5. doi: 10.1136/fn.78.2.F154 PMID: 9577290</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Friedman A. A brief history of rickets. Pediatr Nephrol 2020; 35(10): 1835-41. doi: 10.1007/s00467-019-04366-9 PMID: 31654223</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Creo AL, Thacher TD, Pettifor JM, Strand MA, Fischer PR. Nutritional rickets around the world: An update. Paediatr Int Child Health 2017; 37(2): 84-98. doi: 10.1080/20469047.2016.1248170 PMID: 27922335</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 2009; 160(3): 491-7. doi: 10.1530/EJE-08-0818 PMID: 19095780</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wheeler BJ, Dickson NP, Houghton LA, Ward LM, Taylor BJ. Incidence and characteristics of vitamin D deficiency rickets in New Zea-land children: a New Zealand Paediatric Surveillance Unit study. Aust N Z J Public Health 2015; 39(4): 380-3. doi: 10.1111/1753-6405.12390 PMID: 26122859</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Munns CF, Simm PJ, Rodda CP, et al. Incidence of vitamin D deficiency rickets among Australian children: An Australian Paediatric Sur-veillance Unit study. Med J Aust 2012; 196(7): 466-8. doi: 10.5694/mja11.10662 PMID: 22509879</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Julies P, Lynn RM, Pall K, et al. Nutritional rickets under 16 years: UK surveillance results. Arch Dis Child 2020; 105(6): 587-92. doi: 10.1136/archdischild-2019-317934 PMID: 31949032</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Kubota T, Nakayama H, Kitaoka T, et al. Incidence rate and characteristics of symptomatic vitamin D deficiency in children: A nationwide survey in Japan. Endocr J 2018; 65(6): 593-9. doi: 10.1507/endocrj.EJ18-0008 PMID: 29526992</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ward LM, Gaboury I, Ladhani M, Zlotkin S. Vitamin D-deficiency rickets among children in Canada. CMAJ 2007; 177(2): 161-6. doi: 10.1503/cmaj.061377 PMID: 17600035</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Meyer HE, Skram K, Berge IA, Madar AA, Bjørndalen HJ. Nutritional rickets in Norway: A nationwide register-based cohort study. BMJ Open 2017; 7(5): e015289. doi: 10.1136/bmjopen-2016-015289 PMID: 28554929</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>An online catalog of human genes and genetic disorder: Available from: www.omim.org (Accessed on: Jan 1, 2022).</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 2014; 21(3): 319-29. doi: 10.1016/j.chembiol.2013.12.016 PMID: 24529992</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101(20): 7711-5. doi: 10.1073/pnas.0402490101 PMID: 15128933</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Al Mutair AN, Nasrat GH, Russell DW. Mutation of the CYP2R1 vitamin D 25-hydroxylase in a Saudi Arabian family with severe vitamin D deficiency. J Clin Endocrinol Metab 2012; 97(10): E2022-5. doi: 10.1210/jc.2012-1340 PMID: 22855339</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Molin A, Wiedemann A, Demers N, et al. Vitamin D-dependent rickets type 1B (25-Hydroxylase Deficiency): A rare condition or a misdi-agnosed condition? J Bone Miner Res 2017; 32(9): 1893-9. doi: 10.1002/jbmr.3181 PMID: 28548312</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Thacher TD, Fischer PR, Singh RJ, Roizen J, Levine MA. CYP2R1 Mutations impair generation of 25-hydroxyvitamin D and cause an atypical form of vitamin D deficiency. J Clin Endocrinol Metab 2015; 100(7): E1005-13. doi: 10.1210/jc.2015-1746 PMID: 25942481</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ozden A, Doneray H, Turkyilmaz A. Two novel CYP2R1 mutations in a family with vitamin D-dependent rickets type 1b. Endocrine 2021; 72(3): 852-64. doi: 10.1007/s12020-021-02670-9 PMID: 33715104</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Thacher TD, Levine MA. CYP2R1 mutations causing vitamin D-deficiency rickets. J Steroid Biochem Mol Biol 2017; 173: 333-6. doi: 10.1016/j.jsbmb.2016.07.014 PMID: 27473561</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Bakhamis S, Imtiaz F, Ramzan K, et al. 25-Hydroxylase vitamin D deficiency in 27 Saudi Arabian subjects: A clinical and molecular re-port on CYP2R1 mutations. Endocr Connect 2021; 10(7): 767-75. doi: 10.1530/EC-21-0102 PMID: 34137732</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Fu GK, Lin D, Zhang MY, et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997; 11(13): 1961-70. PMID: 9415400</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kitanaka S, Takeyama K, Murayama A, et al. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998; 338(10): 653-62. doi: 10.1056/NEJM199803053381004 PMID: 9486994</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Koek WNH, Zillikens MC, van der Eerden BCJ, van Leeuwen JPTM. Novel compound heterozygous mutations in the CYP27B1 gene lead to pseudovitamin D-deficient rickets. Calcif Tissue Int 2016; 99(3): 326-31. doi: 10.1007/s00223-016-0165-z PMID: 27364341</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Edouard T, Alos N, Chabot G, Roughley P, Glorieux FH, Rauch F. Short- and long-term outcome of patients with pseudo-vitamin D defi-ciency rickets treated with calcitriol. J Clin Endocrinol Metab 2011; 96(1): 82-9. doi: 10.1210/jc.2010-1340 PMID: 20926527</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Demir K, Kattan WE, Zou M, et al. Novel CYP27B1 gene mutations in patients with vitamin D-dependent rickets type 1A. PLoS One 2015; 10(7): e0131376. doi: 10.1371/journal.pone.0131376 PMID: 26132292</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Tahir S, Demirbilek H, Ozbek MN, Baran RT, Tanriverdi S, Hussain K. Genotype and phenotype characteristics in 22 patients with vita-min D-dependent rickets type I. Horm Res Paediatr 2016; 85(5): 309-17. doi: 10.1159/000444483 PMID: 26982175</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Dursun F, Özgürhan G, Kırmızıbekmez H, Keskin E, Hacıhamdioğlu B. Genetic and clinical characteristics of patients with vitamin D de-pendent rickets type 1A. J Clin Res Pediatr Endocrinol 2019; 11(1): 34-40. doi: 10.4274/jcrpe.galenos.2018.2018.0121 PMID: 30282619</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Kim YM, Jang YY, Jeong JE, Park HJ, Jang JH, Kim JK. A case of vitamin D hydroxylation-deficient rickets type 1A caused by 2 novel pathogenic variants in CYP27B1 gene. Ann Pediatr Endocrinol Metab 2019; 24(2): 137-41. doi: 10.6065/apem.2019.24.2.137 PMID: 31261480</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Li Y, Yuan X, Chen R, et al. Clinical and genetic analysis of two Chinese families with vitamin D-dependent rickets type IA and follow-up. Orphanet J Rare Dis 2020; 15(1): 273. doi: 10.1186/s13023-020-01558-7 PMID: 33004071</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Smith SJ, Rucka AK, Berry JL, et al. Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res 1999; 14(5): 730-9. doi: 10.1359/jbmr.1999.14.5.730 PMID: 10320521</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Chen H, Hewison M, Adams JS. Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: A novel response element-binding protein. J Biol Chem 2006; 281(51): 39114-20. doi: 10.1074/jbc.M608006200 PMID: 17071612</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Feldman D, J Malloy P. Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep 2014; 3: 510. doi: 10.1038/bonekey.2014.5 PMID: 24818002</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Christakos S. Recent advances in our understanding of 1,25-dihydroxyvitamin D3 regulation of intestinal calcium absorption. Arch Biochem Biophys 2012; 523(1): 73-6. doi: 10.1016/j.abb.2011.12.020 PMID: 22230327</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Isojima T, Ishizawa M, Yoshimura K, et al. Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) caused by a VDR mutation: A novel mechanism of dominant inheritance. Bone Rep 2015; 2: 68-73. doi: 10.1016/j.bonr.2015.05.001 PMID: 28377956</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Zhou Y, Wang J, Malloy PJ, Dolezel Z, Feldman D. Compound heterozygous mutations in the vitamin D receptor in a patient with heredi-tary 1,25-dihydroxyvitamin D-resistant rickets with alopecia. J Bone Miner Res 2009; 24(4): 643-51. doi: 10.1359/jbmr.081216 PMID: 19049339</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Malloy PJ, Zhou Y, Wang J, Hiort O, Feldman D. Hereditary vitamin D-resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor. J Bone Miner Res 2011; 26(11): 2710-8. doi: 10.1002/jbmr.484 PMID: 21812032</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Malloy PJ, Tasic V, Taha D, et al. Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Mol Genet Metab 2014; 111(1): 33-40. doi: 10.1016/j.ymgme.2013.10.014 PMID: 24246681</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Ben Ameur S, Silve C, Chabchoub I, et al. Clinical and genetic characterization of tunisian children with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Horm Res Paediatr 2017; 87(1): 23-9. doi: 10.1159/000452886 PMID: 28013309</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Faiyaz-Ul-Haque M, AlDhalaan W, AlAshwal A, et al. Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): Clinical heteroge-neity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation. J Pediatr Endocrinol Metab 2018; 31(8): 861-8. doi: 10.1515/jpem-2017-0312 PMID: 29949513</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Arita K, Nanda A, Wessagowit V, Akiyama M, Alsaleh QA, McGrath JA. A novel mutation in the VDR gene in hereditary vitamin D-resistant rickets. Br J Dermatol 2008; 158(1): 168-71. PMID: 17970811</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Ersoy B, Kiremitci S, Isojima T, Kitanaka S. Successful intermittent intravenous calcium treatment via the peripheral route in a patient with hereditary vitamin D-resistant rickets and alopecia. Horm Res Paediatr 2015; 83(1): 67-72. doi: 10.1159/000367711 PMID: 25573344</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Ma NS, Malloy PJ, Pitukcheewanont P, Dreimane D, Geffner ME, Feldman D. Hereditary vitamin D resistant rickets: Identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy. Bone 2009; 45(4): 743-6. doi: 10.1016/j.bone.2009.06.003 PMID: 19523546</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Abalı S, Tamura M, Turan S, et al. Hereditary vitamin D-resistant rickets: A report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route. J Pediatr Endocrinol Metab 2020; 33(4): 557-62. doi: 10.1515/jpem-2019-0466 PMID: 32049653</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Lucas J, Badia JL, Lucas E, Remon A. Cinacalcet treatment experience in hereditary vitamin D resistant rickets. J Pediatr Endocrinol Metab 2020; 33(2): 313-8. doi: 10.1515/jpem-2019-0258 PMID: 31926093</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Nicolescu RC, Lombet J, Cavalier E. Vitamin D-resistant rickets and cinacalcetone more favorable experience. Front Pediatr 2018; 6: 376. doi: 10.3389/fped.2018.00376 PMID: 30555810</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Gardezi SA, Nguyen C, Malloy PJ, Posner GH, Feldman D, Peleg S. A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1 alpha,25-dihydroxyvitamin D(3). J Biol Chem 2001; 276(31): 29148-56. doi: 10.1074/jbc.M100898200 PMID: 11369766</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Saponaro F, Saba A, Zucchi R. An update on vitamin D metabolism. Int J Mol Sci 2020; 21(18): 6573. doi: 10.3390/ijms21186573 PMID: 32911795</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Roizen JD, Li D, OLear L, et al. CYP3A4 mutation causes vitamin D-dependent rickets type 3. J Clin Invest 2018; 128(5): 1913-8. doi: 10.1172/JCI98680 PMID: 29461981</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Ho BB, Bergwitz C. FGF23 signalling and physiology. J Mol Endocrinol 2021; 66(2): R23-32. doi: 10.1530/JME-20-0178 PMID: 33338030</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Marks J, Debnam ES, Unwin RJ. Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol 2010; 299(2): F285-96. doi: 10.1152/ajprenal.00508.2009 PMID: 20534868</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Beck-Nielsen SS, Mughal Z, Haffner D, et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis 2019; 14(1): 58. doi: 10.1186/s13023-019-1014-8 PMID: 30808384</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garabédian M, Jehan F. PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet 2009; 125(4): 401-11. doi: 10.1007/s00439-009-0631-z PMID: 19219621</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Lin X, Li S, Zhang Z, Yue H. Clinical and genetic characteristics of 153 Chinese patients with x-linked hypophosphatemia. Front Cell Dev Biol 2021; 9: 617738. doi: 10.3389/fcell.2021.617738 PMID: 34141703</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Zheng B, Wang C, Chen Q, et al. Functional characterization of PHEX gene variants in children with X ‐linked hypophosphatemic rickets shows no evidence of genotype-phenotype correlation. J Bone Miner Res 2020; 35(9): 1718-25. doi: 10.1002/jbmr.4035 PMID: 32329911</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Park PG, Lim SH, Lee H, Ahn YH, Cheong HI, Kang HG. Genotype and phenotype analysis in x-linked hypophosphatemia. Front Pediatr 2021; 9: 699767. doi: 10.3389/fped.2021.699767 PMID: 34434907</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Baroncelli GI, Mora S. X-linked hypophosphatemic rickets: Multisystemic disorder in children requiring multidisciplinary management. Front Endocrinol 2021; 12: 688309. doi: 10.3389/fendo.2021.688309 PMID: 34421819</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Vega RA, Opalak C, Harshbarger RJ, et al. Hypophosphatemic rickets and craniosynostosis: A multicenter case series. J Neurosurg Pediatr 2016; 17(6): 694-700. doi: 10.3171/2015.10.PEDS15273 PMID: 26824597</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Houillier P, Salles JP. Biochemical assessment of phosphate homeostasis. Arch Pediatr 2021; 28(7): 588-93. doi: 10.1016/j.arcped.2021.09.001 PMID: 34598836</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Drezner MK, Lyles KW, Haussler MR, Harrelson JM. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treat-ment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest 1980; 66(5): 1020-32. doi: 10.1172/JCI109930 PMID: 6253520</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Haffner D, Emma F, Eastwood DM, et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophos-phataemia. Nat Rev Nephrol 2019; 15(7): 435-55. doi: 10.1038/s41581-019-0152-5 PMID: 31068690</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>White KE, Evans WE, ORiordan JLH, et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000; 26(3): 345-8. doi: 10.1038/81664 PMID: 11062477</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Shimada T, Muto T, Urakawa I, et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to prote-olytic cleavage and causes hypophosphatemia in vivo. Endocrinology 2002; 143(8): 3179-82. doi: 10.1210/endo.143.8.8795 PMID: 12130585</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 2001; 60(6): 2079-86. doi: 10.1046/j.1523-1755.2001.00064.x PMID: 11737582</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Mameli C, Sangiorgio A, Colombo V, et al. Autosomal dominant hypophosphatemic rickets: A case report and review of the literature. Int J Environ Res Public Health 2021; 18(16): 8771. doi: 10.3390/ijerph18168771 PMID: 34444516</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Gribaa M, Younes M, Bouyacoub Y, et al. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab 2010; 28(1): 111-5. doi: 10.1007/s00774-009-0111-5 PMID: 19655082</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Sandal S, Arora V, Verma IC. Hypophosphatemic rickets with R179W mutation in FGFR23 gene - a rare but treatable cause of refractory rickets. Indian J Pediatr 2021; 88(1): 61-3. doi: 10.1007/s12098-020-03335-7 PMID: 32415663</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Liu C, Zhao Z, Wang O, et al. Earlier onset in autosomal dominant hypophosphatemic rickets of R179 than R176 mutations in fibroblast growth factor 23: Report of 20 Chinese cases and review of the literature. Calcif Tissue Int 2019; 105(5): 476-86. doi: 10.1007/s00223-019-00597-y PMID: 31486862</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Kapelari K, Köhle J, Kotzot D, Högler W. Iron supplementation associated with loss of phenotype in autosomal dominant hypophos-phatemic rickets. J Clin Endocrinol Metab 2015; 100(9): 3388-92. doi: 10.1210/jc.2015-2391 PMID: 26186302</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Liu C, Li X, Zhao Z, et al. Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophos-phatemic rickets. Osteoporos Int 2021; 32(4): 737-45. doi: 10.1007/s00198-020-05649-w PMID: 32995940</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Imel EA, Liu Z, Coffman M, Acton D, Mehta R, Econs MJ. Oral iron replacement normalizes fibroblast growth factor 23 in iron‐deficient patients with autosomal dominant hypophosphatemic rickets. J Bone Miner Res 2020; 35(2): 231-8. doi: 10.1002/jbmr.3878 PMID: 31652009</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Lorenz-Depiereux B, Bastepe M, Benet-Pagès A, et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone ma-trix protein in the regulation of phosphate homeostasis. Nat Genet 2006; 38(11): 1248-50. doi: 10.1038/ng1868 PMID: 17033625</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Mäkitie O, Pereira RC, Kaitila I, et al. Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation. J Bone Miner Res 2010; 25(10): 2165-74. doi: 10.1002/jbmr.105 PMID: 20499351</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006; 38(11): 1310-5. doi: 10.1038/ng1905 PMID: 17033621</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Levy-Litan V, Hershkovitz E, Avizov L, et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 2010; 86(2): 273-8. doi: 10.1016/j.ajhg.2010.01.010 PMID: 20137772</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Höppner J, Kornak U, Sinningen K, Rutsch F, Oheim R, Grasemann C. Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) due to ENPP1-deficiency. Bone 2021; 153: 116111. doi: 10.1016/j.bone.2021.116111 PMID: 34252603</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Brachet C, Mansbach AL, Clerckx A, Deltenre P, Heinrichs C. Hearing loss is part of the clinical picture of ENPP1 loss of function muta-tion. Horm Res Paediatr 2014; 81(1): 63-6. doi: 10.1159/000354661 PMID: 24216977</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Kotwal A, Ferrer A, Kumar R, et al. Clinical and biochemical phenotypes in a family with ENPP1 mutations. J Bone Miner Res 2020; 35(4): 662-70. doi: 10.1002/jbmr.3938 PMID: 31826312</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Kinoshita Y, Hori M, Taguchi M, Fukumoto S. Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophos-phatemia. Bone 2014; 67: 145-51. doi: 10.1016/j.bone.2014.07.009 PMID: 25026495</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Seidahmed MZ, Alazami AM, Abdelbasit OB, et al. Report of a case of Raine syndrome and literature review. Am J Med Genet A 2015; 167(10): 2394-8. doi: 10.1002/ajmg.a.37159 PMID: 25974638</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Faundes V, Castillo-Taucher S, Gonzalez-Hormazabal P, Chandler K, Crosby A, Chioza B. Raine syndrome: An overview. Eur J Med Genet 2014; 57(9): 536-42. doi: 10.1016/j.ejmg.2014.07.001 PMID: 25019372</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Rafaelsen SH, Raeder H, Fagerheim AK, et al. Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification. J Bone Miner Res 2013; 28(6): 1378-85. doi: 10.1002/jbmr.1850 PMID: 23325605</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Mameli C, Zichichi G, Mahmood N, et al. Natural history of non-lethal Raine syndrome during childhood. Orphanet J Rare Dis 2020; 15(1): 93. doi: 10.1186/s13023-020-01373-0 PMID: 32299476</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Eltan M, Alavanda C, Yavas Abali Z, et al. A rare cause of hypophosphatemia: Raine syndrome changing clinical features with age. Calcif Tissue Int 2020; 107(1): 96-103. doi: 10.1007/s00223-020-00694-3 PMID: 32337609</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>White KE, Cabral JM, Davis SI, et al. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet 2005; 76(2): 361-7. doi: 10.1086/427956 PMID: 15625620</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Kuthiroly S, Yesodharan D, Ghosh A, White K, Nampoothiri S. Osteoglophonic dysplasia: Phenotypic and radiological clues. J Pediatr Genet 2017; 6(4): 247-51. doi: 10.1055/s-0037-1602816 PMID: 29147600</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinicians guide to X-linked hypophosphatemia. J Bone Miner Res 2011; 26(7): 1381-8. doi: 10.1002/jbmr.340 PMID: 21538511</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Al Juraibah F, Al Amiri E, Al Dubayee M, et al. Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries. Arch Osteoporos 2021; 16(1): 52. doi: 10.1007/s11657-021-00879-9 PMID: 33660084</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Carpenter TO, Whyte MP, Imel EA, et al. Burosumab therapy in children with x-linked hypophosphatemia. N Engl J Med 2018; 378(21): 1987-98. doi: 10.1056/NEJMoa1714641 PMID: 29791829</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Imel EA, Glorieux FH, Whyte MP, et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: A ran-domised, active-controlled, open-label, phase 3 trial. Lancet 2019; 393(10189): 2416-27. doi: 10.1016/S0140-6736(19)30654-3 PMID: 31104833</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Levi M, Gratton E, Forster IC, et al. Mechanisms of phosphate transport. Nat Rev Nephrol 2019; 15(8): 482-500. doi: 10.1038/s41581-019-0159-y PMID: 31168066</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Lorenz-Depiereux B, Benet-Pages A, Eckstein G, et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 2006; 78(2): 193-201. doi: 10.1086/499410 PMID: 16358215</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Dasgupta D, Wee MJ, Reyes M, et al. Mutations in SLC34A3/ NPT2c are associated with kidney stones and nephrocalcinosis. J Am Soc Nephrol 2014; 25(10): 2366-75. doi: 10.1681/ASN.2013101085 PMID: 24700880</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Tencza AL, Ichikawa S, Dang A, et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: Presentation as hypercalciuria and nephrolithiasis. J Clin Endocrinol Metab 2009; 94(11): 4433-8. doi: 10.1210/jc.2009-1535 PMID: 19820004</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Mejia-Gaviria N, Gil-Peña H, Coto E, Pérez-Menéndez TM, Santos F. Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: A case report. Orphanet J Rare Dis 2010; 5(1): 1. doi: 10.1186/1750-1172-5-1 PMID: 20074341</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Phulwani P, Bergwitz C, Jaureguiberry G, Rasoulpour M, Estrada E. Hereditary hypophosphatemic rickets with hypercalciuria and nephro-lithiasis-Identification of a novel SLC34A3/NaPi-IIc mutation. Am J Med Genet A 2011; 155(3): 626-33. doi: 10.1002/ajmg.a.33832 PMID: 21344632</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Gordon RJ, Li D, Doyle D, Zaritsky J, Levine MA. Digenic heterozygous mutations in SLC34A3 and SLC34A1 cause dominant hypo-phosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab 2020; 105(7): 2392-400. doi: 10.1210/clinem/dgaa217 PMID: 32311027</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Turan I, Erdem S, Kotan LD, et al. Experience with the targeted next-generation sequencing in the diagnosis of hereditary hypophos-phatemic rickets. J Pediatr Endocrinol Metab 2021; 34(5): 639-48. doi: 10.1515/jpem-2020-0624 PMID: 33852231</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Cebeci AN, Zou M, BinEssa HA, et al. Mutation of SGK3, a novel regulator of renal phosphate transport, causes autosomal dominant hypophosphatemic rickets. J Clin Endocrinol Metab 2020; 105(6): 1840-50. doi: 10.1210/clinem/dgz260 PMID: 31821448</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Trepiccione F, Capasso G. SGK3: A novel regulator of renal phosphate transport? Kidney Int 2011; 80(1): 13-5. doi: 10.1038/ki.2011.60 PMID: 21673735</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Hawkes CP, Li D, Hakonarson H, Meyers KE, Thummel KE, Levine MA. CYP3A4 induction by rifampin: An alternative pathway for vitamin D inactivation in patients with CYP24A1 mutations. J Clin Endocrinol Metab 2017; 102(5): 1440-6. doi: 10.1210/jc.2016-4048 PMID: 28324001</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>Bertholet-Thomas A, Tram N, Dubourg L, Lemoine S, Molin A, Bacchetta J. Fluconazole as a new therapeutic tool to manage patients with NPTIIc (SLC34A3) mutation: A case report. Am J Kidney Dis 2019; 73(6): 886-9. doi: 10.1053/j.ajkd.2018.12.026 PMID: 30765103</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Thiele S, Werner R, Stubbe A, Hiort O, Hoeppner W. Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting. Eur J Endocrinol 2020; 183(5): 497-504. doi: 10.1530/EJE-20-0275 PMID: 33107440</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>Beck-Nielsen SS, Brixen K, Gram J, Brusgaard K. Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet 2012; 57(7): 453-8. doi: 10.1038/jhg.2012.56 PMID: 22695891</mixed-citation></ref></ref-list></back></article>
